Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS Expanded Access Protocol: Repeated Administration of Nurown®(Autologous MSC-NTF Cells)for the Treatm ...
Intermediate-size Patient Population Expanded Access Protocol: Repeated Administration of Nurown® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) for the Treatment of Amyotrophic Lateral Sclerosis (ALS) Intermediate-size Patient Population Expanded Access Protocol: Repeated Administration of Nurown®(Au ...
Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients
A Phase 3, Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate Efficacy and Safety of Repeated Administration of NurOwn® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) in Participants With ALS A Phase 3, Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate Efficacy and Sa ...
Amyotrophic Lateral Sclerosis (ALS)
Biological: NurOwn®(MSC-NTFcells);Other: Placebo;Other: Bone Marrow aspiration
Brainstorm-Cell Therapeutics
California Institute for Regenerative Medicine (CIRM)